B-Cell Non-Hodgkins Lymphoma
2 clinical trials · Condition
◉ Watch B-Cell Non-Hodgkins Lymphoma
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies (NCT02924402) | Xencor, Inc. | 2016-10-01 |
Track B-Cell Non-Hodgkins Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.